SG162687A1 - Caustic stable chromatography ligands - Google Patents

Caustic stable chromatography ligands

Info

Publication number
SG162687A1
SG162687A1 SG200908285-0A SG2009082850A SG162687A1 SG 162687 A1 SG162687 A1 SG 162687A1 SG 2009082850 A SG2009082850 A SG 2009082850A SG 162687 A1 SG162687 A1 SG 162687A1
Authority
SG
Singapore
Prior art keywords
ligands
chromatography ligands
stable chromatography
caustic stable
caustic
Prior art date
Application number
SG200908285-0A
Other languages
English (en)
Inventor
Nanying Bian
Neil Soice
Shari Spector
Kara Levine
Original Assignee
Millipore Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42112635&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG162687(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Millipore Corp filed Critical Millipore Corp
Publication of SG162687A1 publication Critical patent/SG162687A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • B01J20/3244—Non-macromolecular compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • B01J20/3268—Macromolecular compounds
    • B01J20/3272—Polymers obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
    • B01J20/3274—Proteins, nucleic acids, polysaccharides, antibodies or antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/50—Conditioning of the sorbent material or stationary liquid
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/305—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F)
    • G01N2333/31—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F) from Staphylococcus (G)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG200908285-0A 2008-12-24 2009-12-14 Caustic stable chromatography ligands SG162687A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20366408P 2008-12-24 2008-12-24

Publications (1)

Publication Number Publication Date
SG162687A1 true SG162687A1 (en) 2010-07-29

Family

ID=42112635

Family Applications (2)

Application Number Title Priority Date Filing Date
SG200908285-0A SG162687A1 (en) 2008-12-24 2009-12-14 Caustic stable chromatography ligands
SG2013076492A SG195555A1 (en) 2008-12-24 2009-12-14 Caustic stable chromatography ligands

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2013076492A SG195555A1 (en) 2008-12-24 2009-12-14 Caustic stable chromatography ligands

Country Status (7)

Country Link
US (3) US10072050B2 (fr)
EP (3) EP2799550B1 (fr)
JP (7) JP5329381B2 (fr)
CN (7) CN105111289B (fr)
DK (1) DK2518151T3 (fr)
ES (3) ES2406359T5 (fr)
SG (2) SG162687A1 (fr)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8592555B2 (en) * 2008-08-11 2013-11-26 Emd Millipore Corporation Immunoglobulin-binding proteins with improved specificity
EP2339339A4 (fr) * 2008-09-25 2016-10-12 Jsr Corp Charge pour chromatographie d'affinité
SG162687A1 (en) 2008-12-24 2010-07-29 Millipore Corp Caustic stable chromatography ligands
CN102272145B (zh) * 2009-01-12 2014-07-30 通用电气健康护理生物科学股份公司 亲和色谱基质
US9403883B2 (en) * 2009-03-24 2016-08-02 Kaneka Corporation Protein having affinity for immunoglobulin, and immunoglobulin-binding affinity ligand
CN102834415A (zh) * 2010-03-24 2012-12-19 Jsr株式会社 亲和色谱用填充剂以及离析免疫球蛋白的方法
US9051375B2 (en) 2010-12-21 2015-06-09 The University Of Western Ontario Alkali-resistant variants of protein A and their use in affinity chromatography
US9040661B2 (en) 2010-12-21 2015-05-26 Jsr Corporation Support for affinity chromatography and method for isolating immunoglobulin
JP5812303B2 (ja) 2011-06-03 2015-11-11 国立研究開発法人産業技術総合研究所 酸性域での親和性が低下したプロテインａ変異型タンパク質及び抗体捕捉剤
SG10201604559TA (en) 2011-06-08 2016-07-28 Emd Millipore Corp Chromatography matrices including novel staphylococcus aureus protein a based ligands
US20130017387A1 (en) 2011-07-12 2013-01-17 James Iii William H Chemically durable porous glass with enhanced alkaline resistance
US9657055B2 (en) * 2011-11-30 2017-05-23 Ge Healthcare Bioprocess R&D Ab Affinity chromatography matrix
EP2682168A1 (fr) 2012-07-02 2014-01-08 Millipore Corporation Dispositif de tirage et métier à filer
CN107188926B (zh) 2012-06-29 2021-02-09 Emd密理博公司 在蛋白纯化过程中灭活病毒的方法
SG11201505901YA (en) * 2013-03-14 2015-08-28 Emd Millipore Corp Methods of increasing protein purity using protein a based chromatography
US9896486B2 (en) * 2013-07-10 2018-02-20 Ge Healthcare Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
CN114560906A (zh) * 2013-09-04 2022-05-31 Emd密理博公司 清洗基于a蛋白的亲和色谱柱的方法
US10610807B2 (en) 2014-01-17 2020-04-07 Repligen Corporation Sterilizing chromatography columns
JP6369807B2 (ja) * 2014-10-21 2018-08-08 株式会社プロテイン・エクスプレス プロテインｌ変異体
US11566082B2 (en) 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
CN105688841B (zh) * 2014-11-25 2018-02-23 中国科学院大连化学物理研究所 一种免疫吸附高分子微球及其制备和应用
CN106140110B8 (zh) * 2015-04-16 2018-02-23 中国科学院大连化学物理研究所 一种低密度脂蛋白吸附剂的制备方法
FR3035799B1 (fr) * 2015-05-06 2017-05-05 Elicityl Support pour la purification de liquides biologiques
FR3035794B1 (fr) * 2015-05-06 2017-05-05 Elicityl Procede pour la purification du sang total ou d'un produit issu du sang
JP6126644B2 (ja) 2015-05-29 2017-05-10 Ｈｏｙａ Ｃａｎｄｅｏ Ｏｐｔｒｏｎｉｃｓ株式会社 光照射装置
JPWO2017022672A1 (ja) * 2015-07-31 2018-07-05 株式会社カネカ 免疫グロブリン結合性改変型タンパク質
US10697982B2 (en) * 2015-09-08 2020-06-30 Merck Patent Gmbh Methods of evaluating quality of a chromatography media which binds anti-A or anti-B antibodies
US10697983B2 (en) * 2015-09-08 2020-06-30 Merck Patent Gmbh Methods of evaluating quality of media suitable for removing anti-A or anti-B antibodies
ES2909833T3 (es) 2016-05-11 2022-05-10 Cytiva Bioprocess R & D Ab Método de limpieza y/o desinfección de una matriz de separación
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
CN109311949B (zh) 2016-05-11 2022-09-16 思拓凡生物工艺研发有限公司 储存分离基质的方法
US10889615B2 (en) 2016-05-11 2021-01-12 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
US10654887B2 (en) 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
ES2874974T3 (es) 2016-05-11 2021-11-05 Cytiva Bioprocess R & D Ab Matriz de separación
KR101857953B1 (ko) 2016-07-06 2018-05-16 아미코젠주식회사 알칼리 내성이 증가된 변이 면역글로불린 결합 단백질
JP2020504172A (ja) 2016-12-12 2020-02-06 フラー エス．アー．エール．エル． 免疫グロブリン結合ポリペプチドおよびオリゴペプチドの免疫グロブリン結合容量を増加するための組成物および方法
WO2018162501A1 (fr) 2017-03-07 2018-09-13 Jmva Biotech Ab Surfaces adsorbantes modifiées
US11155575B2 (en) 2018-03-21 2021-10-26 Waters Technologies Corporation Non-antibody high-affinity-based sample preparation, sorbent, devices and methods
JP7335881B2 (ja) * 2018-08-24 2023-08-30 Jsr株式会社 イムノグロブリン結合タンパク質、及びそれを用いたアフィニティー担体
EP3917942A1 (fr) * 2019-02-01 2021-12-08 Navigo Proteins Gmbh Protéines de liaison à l'immunoglobuline pour purification par affinité
US20230295223A1 (en) * 2020-07-15 2023-09-21 Navigo Proteins Gmbh Immunoglobulin binding proteins for affinity purification
CN112461943A (zh) * 2020-10-12 2021-03-09 河南省奶牛生产性能测定有限公司 一种牛乳中免疫球蛋白igG高效液相色谱检测方法
GB202018588D0 (en) 2020-11-26 2021-01-13 Cytiva Bioprocess R & D Ab Separation matrix
EP4269590A1 (fr) * 2020-12-22 2023-11-01 Protenova Co., Ltd. Polypeptide se liant aux immunoblobulines
GB202113626D0 (en) 2021-09-24 2021-11-10 Cytiva Bioprocess R & D Ab FC binding polypeptides

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8204810L (sv) 1982-08-23 1984-02-24 Pharmacia Fine Chemicals Ab Hybrid-dna-molekyl, transformerad mikroorganism och sett att framstella protein a
US5151350A (en) * 1982-10-27 1992-09-29 Repligen Corporation Cloned genes encoding recombinant protein a
US4617266A (en) * 1983-04-28 1986-10-14 Genex Corporation Production of Protein A
SE8505922D0 (sv) * 1985-12-13 1985-12-13 Kabigen Ab Construction of an igg binding protein to facilitate downstream processing using protein engineering
DE3771513D1 (de) * 1986-01-29 1991-08-29 Marukomu Kk Rotationsviskosimeter.
US5260373A (en) * 1987-03-13 1993-11-09 Repligen Corporation Immobilized immunoglobulin-binding proteins
US5084559A (en) * 1987-03-27 1992-01-28 Repligen Corporation Protein a domain mutants
US5089473A (en) 1988-08-29 1992-02-18 Monsanto Company Somatotropin variants and their use
GB8902770D0 (en) 1989-02-08 1989-03-30 Bioprocessing Ltd Improvements in or relating to supports for immunoaffinity separations
US4879378A (en) * 1989-03-30 1989-11-07 Union Carbide Chemicals And Plastics Company Inc. Polysiloxanes with pendant sterically hindered phenol moiety connected to the silicon atom via a carbonylyoxy-containing link
US5401650A (en) * 1990-10-24 1995-03-28 The Mount Sinai School Of Medicine Of The City University Of New York Cloning and expression of biologically active α-galactosidase A
US5198531A (en) * 1991-06-14 1993-03-30 Research Diagnostic Antibodies Polymeric resin for peptide synthesis
WO1993002107A1 (fr) * 1991-07-25 1993-02-04 Oriental Yeast Co., Ltd. Proteine artificielle de combinaison avec les immunoglobulines
US5240680A (en) * 1991-12-19 1993-08-31 Chiron Corporation Automated apparatus for use in peptide synthesis
US5573905A (en) * 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
SE9400088D0 (sv) 1994-01-14 1994-01-14 Kabi Pharmacia Ab Bacterial receptor structures
SE9503925D0 (sv) 1995-11-07 1995-11-07 Pharmacia Biotech Ab Separationsmedium för IgG
US6447777B1 (en) 1996-03-29 2002-09-10 David S. Terman Polymerized staphylococcal protein a for treatment of diseases
US6013763A (en) * 1996-06-04 2000-01-11 Genentech, Inc. Peptide variants of protein A
US5856452A (en) * 1996-12-16 1999-01-05 Sembiosys Genetics Inc. Oil bodies and associated proteins as affinity matrices
EP1042459A4 (fr) * 1997-12-24 2003-07-23 Diatech Pty Ltd Molecules bifonctionnelles
GB9823071D0 (en) 1998-10-21 1998-12-16 Affibody Technology Ab A method
US6589529B1 (en) * 1998-10-30 2003-07-08 Children's Hospital Medical Center Rotavirus subunit vaccine
SE9901379D0 (sv) 1999-04-19 1999-04-19 Pharmacia & Upjohn Ab Receptor structures
US6602977B1 (en) * 1999-04-19 2003-08-05 Biovitrum Ab Receptor structures
US7163686B1 (en) * 1999-05-15 2007-01-16 The Regents Of The University Of California Protein A based binding domains with desirable activities
EP1181052A4 (fr) * 1999-05-15 2004-08-11 Univ California San Diego Domaines avec activites voulues fondes sur la proteine a
AT410798B (de) * 2001-01-26 2003-07-25 Cistem Biotechnologies Gmbh Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
DE10155984A1 (de) † 2001-11-15 2003-05-28 Boehringer Ingelheim Pharma Verfahren zur Reduktion des Liganden-leakage von Affinitätschromatographie-Matrices
US20050171339A1 (en) * 2001-12-28 2005-08-04 Izumi Sugo Method of stabilizing protein
SE0200943D0 (sv) * 2002-03-25 2002-03-25 Amersham Biosciences Ab Mutant protein
US7709209B2 (en) * 2002-03-25 2010-05-04 Ge Healthcare Bio-Sciences Ab Protein ligands
US7083948B1 (en) * 2002-12-24 2006-08-01 Immunex Corporation Polypeptide purification reagents and methods for their use
GB0304576D0 (en) * 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
AU2004215653B2 (en) 2003-02-28 2011-03-17 Lonza Biologics Plc. Antibody purification by protein A and ion exchange chromatography
JP4871126B2 (ja) * 2003-07-04 2012-02-08 アフィボディ・アーベー Ｈｅｒ２に対する結合親和性を有するポリペプチド
US7956165B2 (en) 2003-07-24 2011-06-07 Affisink Biotechnology Ltd. Compositions and methods for purifying and crystallizing molecules of interest
EP3095793B1 (fr) † 2003-07-28 2020-03-25 Genentech, Inc. Réduction de protéine a pendant une chromatographie d'affinité sur protéine a
CA2541015A1 (fr) * 2003-10-03 2005-04-14 Genentech, Inc. Proteines de liaison a l'igf
JP2005220028A (ja) * 2004-02-03 2005-08-18 Rikogaku Shinkokai タンパク質の高密度配向集積方法
EP1564286A1 (fr) 2004-02-11 2005-08-17 Université de Liège Protéines hybrides de la beta-lactamase classe A
EP2251425B1 (fr) 2004-07-06 2016-04-20 Kaneka Corporation Procédé de production d'un assimilé de la protéine A à l'aide de bactérie Brevibacillus
KR20070072510A (ko) * 2004-08-30 2007-07-04 론자 바이올로직스 피엘씨 항체 정제를 위한 친화도- 및 이온 교환- 크로마토그래피
US8728828B2 (en) * 2004-12-22 2014-05-20 Ge Healthcare Bio-Sciences Ab Purification of immunoglobulins
US20080254551A1 (en) 2004-12-30 2008-10-16 Achsel Tilmann Immunoprecipitaion-Based Method to Purify and Characterise Biological Macromolecular Complexes
ATE490268T1 (de) 2005-03-01 2010-12-15 Affibody Ab Tnf-alhpa-bindendes polypeptid, anwendungen davon und verfahren, bei denen dieses verwendet wird
JP2006304633A (ja) * 2005-04-26 2006-11-09 Apro Life Science Institute Inc イムノグロブリン結合タンパク質
EP1896504B1 (fr) 2005-06-17 2012-11-21 Wyeth LLC Procedes de purification des anticorps contenant la region fc
WO2007019376A2 (fr) * 2005-08-03 2007-02-15 Rq Bioscience, Inc. Methodes et compositions pour le diagnostic de maladies renales mediees par l'iga et l'igm
CN101258175B (zh) * 2005-08-03 2011-11-16 默克专利股份公司 亲水交联聚合物
WO2007061936A2 (fr) * 2005-11-18 2007-05-31 New England Medical Center Hospitals, Inc. Elimination de iga1 anormale dans des maladies a depot d'iga1
WO2007067597A2 (fr) * 2005-12-05 2007-06-14 Trinity Biosystems, Inc. Procedes et compositions d'apport sans aiguille de partenaires de liaison
EP1974215B1 (fr) * 2006-01-06 2017-12-27 EMD Millipore Corporation Matrices de chromatographie d'affinite et procedes de fabrication et d'utilisation correspondants
JP4179517B2 (ja) * 2006-02-21 2008-11-12 プロテノバ株式会社 イムノグロブリン親和性リガンド
EP1992692B1 (fr) 2006-02-21 2013-01-09 Protenova Co., Ltd. Ligand présentant une affinité pour les immunoglobulines
US20080096819A1 (en) * 2006-05-02 2008-04-24 Allozyne, Inc. Amino acid substituted molecules
GB0610776D0 (en) 2006-05-31 2006-07-12 Univ Bath Novel applications for staphylococcus aureus Sbi protein
CN100507100C (zh) 2006-06-29 2009-07-01 福建众和股份有限公司 炉甘石粘胶纤维及其制备方法和应用
CA2664530C (fr) 2006-09-29 2015-11-17 Ge Healthcare Bio-Sciences Ab Ligand de chromatographie comprenant un domaine c issu de la proteine a de staphylococcus aureus pour l'isolement d'anticorps
JP5004165B2 (ja) * 2006-10-10 2012-08-22 独立行政法人産業技術総合研究所 タンパク質の配向制御固定化に適したタンパク質
WO2008127457A2 (fr) 2006-12-06 2008-10-23 Repligen Corporation Acides nucléiques codant pour la protéine recombinée a
US8362217B2 (en) 2006-12-21 2013-01-29 Emd Millipore Corporation Purification of proteins
ATE526017T1 (de) 2007-01-22 2011-10-15 Genentech Inc Abscheidung von polyelektrolyten und reinigung von antikörpern
JP2008255046A (ja) * 2007-04-04 2008-10-23 Toray Ind Inc 融合タンパク質、これを用いた抗体捕捉担体および抗原検出法
JP2008266221A (ja) * 2007-04-20 2008-11-06 National Institute Of Advanced Industrial & Technology アミノ末端１箇所で配向制御固定化された固定化タンパク質
JP5522723B2 (ja) * 2007-05-21 2014-06-18 ノマディックバイオサイエンス株式会社 新規ポリペプチド，アフィニティークロマトグラフィー用材，及びイムノグロブリンの分離及び／又は精製方法
SG149759A1 (en) * 2007-07-10 2009-02-27 Millipore Corp Media for affinity chromatography
JP2009071766A (ja) 2007-09-18 2009-04-02 Panasonic Corp 受信端末装置
WO2009138484A2 (fr) 2008-05-15 2009-11-19 Novo Nordisk A/S Procédé de purification d'anticorps
US9238810B2 (en) 2008-06-05 2016-01-19 Affibody Ab Polypeptide
US8592555B2 (en) * 2008-08-11 2013-11-26 Emd Millipore Corporation Immunoglobulin-binding proteins with improved specificity
SG162687A1 (en) 2008-12-24 2010-07-29 Millipore Corp Caustic stable chromatography ligands
CN102272145B (zh) 2009-01-12 2014-07-30 通用电气健康护理生物科学股份公司 亲和色谱基质
US9403883B2 (en) * 2009-03-24 2016-08-02 Kaneka Corporation Protein having affinity for immunoglobulin, and immunoglobulin-binding affinity ligand
CN103228328A (zh) 2010-11-29 2013-07-31 通用电气健康护理生物科学股份公司 亲和色谱基质
CN103269761B (zh) 2010-12-20 2016-05-18 通用电气健康护理生物科学股份公司 亲和色谱基质
SG10201604559TA (en) * 2011-06-08 2016-07-28 Emd Millipore Corp Chromatography matrices including novel staphylococcus aureus protein a based ligands

Also Published As

Publication number Publication date
JP7110287B2 (ja) 2022-08-01
DK2518151T3 (en) 2015-07-20
US11084851B2 (en) 2021-08-10
EP2202310A2 (fr) 2010-06-30
EP2202310A3 (fr) 2010-10-20
ES2406359T5 (es) 2016-03-15
JP2012229212A (ja) 2012-11-22
ES2406359T3 (es) 2013-06-06
US20100221844A1 (en) 2010-09-02
JP5329381B2 (ja) 2013-10-30
EP2518151A1 (fr) 2012-10-31
EP2799550A1 (fr) 2014-11-05
CN101775069A (zh) 2010-07-14
ES2464019T3 (es) 2014-05-29
EP2202310B1 (fr) 2013-03-20
EP2799550B1 (fr) 2017-03-01
CN103601794A (zh) 2014-02-26
US10072050B2 (en) 2018-09-11
CN115073568A (zh) 2022-09-20
EP2518151B1 (fr) 2014-04-09
ES2623889T3 (es) 2017-07-12
JP2014015464A (ja) 2014-01-30
JP2010156687A (ja) 2010-07-15
JP6755908B2 (ja) 2020-09-16
CN105111289A (zh) 2015-12-02
JP2022084822A (ja) 2022-06-07
US20210388036A1 (en) 2021-12-16
CN105111289B (zh) 2019-12-24
CN108864263A (zh) 2018-11-23
EP2202310B2 (fr) 2016-01-20
CN108864262A (zh) 2018-11-23
JP2019023188A (ja) 2019-02-14
JP2017031151A (ja) 2017-02-09
SG195555A1 (en) 2013-12-30
EP2518151B9 (fr) 2019-01-09
JP2021004240A (ja) 2021-01-14
CN108912216A (zh) 2018-11-30
US20180362595A1 (en) 2018-12-20

Similar Documents

Publication Publication Date Title
SG162687A1 (en) Caustic stable chromatography ligands
SG159458A1 (en) Novel immunoglobulin-binding proteins with improved specificity
MY156315A (en) Anti-vegf antibodies
EA200970580A1 (ru) Таннат разагилина
MY167231A (en) Amino acid sequences directed against IL-17A, IL-17F and/or IL17-A/F and polypeptides comprising the same
CY1118343T1 (el) Αντισωματα συνδεσης twεακ
MX2009004167A (es) Anticuerpos que enlazan epitopos cxcr7.
IN2012DN00640A (fr)
TN2010000213A1 (en) Wise binding antibodies and epitopes
MX2014005108A (es) Constructos de polipeptidos y sus usos.
WO2013109302A3 (fr) Matrices de chromatographie comprenant de nouveaux ligands à base de protéine a de staphylococcus aureus
MY147732A (en) Process for the preparation of 2-substituted-5- (1-alkylthio) alkylpyridines
EA200970909A1 (ru) Новый антиген, ассоциированный с новообразованными сосудами опухолевых метастазов
IN2012DN05169A (fr)
DK2344540T3 (da) Cd86-antagonist multimål bindingsproteiner
EA201390785A1 (ru) Антитела, обладающие низкой аффинностью к рецепторам гематоэнцефалического барьера, и их применения
SG10201408401RA (en) Coiled coil and/or tether containing protein complexes and uses thereof
EP2185197A4 (fr) Nouvelles compositions d'une solution contenant un facteur cellulaire
EA201171325A1 (ru) Нуклеиновые кислоты, связывающиеся с гепсидином
TR201903403T4 (tr) İmmünoglobulin preparatı.
EP2516624A4 (fr) Lignée cellulaire 3m
MX2011008752A (es) Variantes de union a anti-albumina de suero mejoradas.
EA201291065A1 (ru) Антитела против vla-4
CA2705357C (fr) Formulations pour proteines hybrides taci-immunoglobuline
MX2010007716A (es) Combinacion de una proteina de fusion del anticuerpo-il-2 de anti-edb fibronectina y una molecula que se une a celulas b, progenitores de la celula b y/o sus contrapartes cancerigenas.